Welcome to our dedicated page for Viewbix SEC filings (Ticker: VBIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Viewbix Inc. (VBIX) SEC filings page on Stock Titan provides direct access to the company’s U.S. Securities and Exchange Commission disclosures, including Forms 8-K, registration statements on Form S-1 and related documents. These filings explain how Viewbix structures its digital advertising operations, raises capital and pursues its planned acquisition of Quantum X Labs Ltd., a multi-disciplinary quantum technology hub.
Recent Form 8-K reports detail key transactions such as non-binding term sheets and a securities exchange agreement with Quantum X Labs, under which Viewbix agreed to issue common stock and pre-funded warrants in exchange for up to 100%, and not less than 85%, of Quantum’s share capital. The filings also describe potential earn-out securities tied to milestones like patent filings, portfolio company transactions and capital raises at specified valuations. Other 8-Ks cover the sale of Cortex Media Group Ltd. by subsidiary Gix Media Ltd., private placements of common stock and warrants, and board changes.
Viewbix’s S-1 registration statements outline its business as a digital advertising platform, its classification in the Internet Content & Information industry, and the terms of warrant-related resales. These documents provide context on how the company’s search and digital content activities operate through subsidiaries, and how financing arrangements such as credit facility–related warrants are structured.
Stock Titan’s platform enhances these filings with AI-powered summaries that highlight the core terms of each transaction, explain complex securities such as pre-funded warrants and earn-out structures, and point out how acquisitions like Quantum X Labs could affect Viewbix’s corporate structure. Users can review real-time updates as new filings appear in EDGAR and quickly locate information related to offerings, securities exchange agreements, insider-related transactions reported on Forms 3, 4 or 5 (when filed), and annual or quarterly reports such as Forms 10-K and 10-Q. This helps investors and researchers understand the regulatory record behind VBIX stock without reading every filing in full.
Viewbix Inc. is rebranding as Quantum X Labs Inc. and shifting its market identity toward quantum technologies while keeping its existing digital advertising operations. The company’s Nasdaq ticker will change from VBIX to QXL, with trading under the new symbol beginning on April 30, 2026.
The filing states that shareholder rights are unchanged, the CUSIP number remains the same, and existing stock certificates stay valid, with new certificates reflecting the Quantum X Labs name issued over time. Through wholly owned subsidiary Quantum X Labs Ltd. and several partially owned portfolio companies, the group is focusing on quantum computing, quantum error correction, sensing, navigation, atomic clocks, cybersecurity, and life-science applications, alongside its legacy Gix Media and Metagramm software businesses.
Viewbix Inc. files a registration statement to permit the resale of up to 1,472,000 shares of common stock, consisting of 800,000 shares issued in a private placement, 640,000 shares issuable on exercise of Common Warrants, and 32,000 shares issuable on exercise of Advisor Warrants. The resale proceeds will go to the selling stockholders; the company will receive proceeds only if warrants are exercised for cash. The prospectus states shares outstanding were 13,336,392 as of April 1, 2026. The filing also discloses the March 4, 2026 acquisition of Quantum (Quantum became a wholly-owned subsidiary) and potential additional issuance of up to 12,702,847 Earn-Out Securities upon achievement of specified milestones.
Viewbix Inc. director-associated entity Amitay Weiss Management Ltd. completed an open-market sale of 30,296 shares of common stock at $2.00 per share on March 31, 2026. The shares were reported as held indirectly, and the filing shows 0 shares remaining following the transaction.
Viewbix Inc. files its annual report outlining a company transforming from a pure ad-tech player into a mix of digital advertising, quantum technology and enterprise AI.
The core business remains Gix Media’s search-based digital advertising platform, which relies heavily on a single major search-engine customer that supplied about 81% of Gix Media’s 2025 revenue of $1.2 million. Viewbix sold its Cortex content unit in November 2025 and now presents Cortex as discontinued operations.
Growth now leans on two new wholly owned subsidiaries: Quantum X Labs, a quantum-technology hub with six portfolio companies, and Metagramm, an AI writing-assistance provider. The report highlights substantial doubt about the company’s ability to continue as a going concern, a need to raise additional capital, heightened data-privacy regulation, intense competition from giants such as Google and Microsoft, and geopolitical and currency risks tied to operations in Israel.
Viewbix Inc. schedules a beneficial ownership disclosure showing Capitalink Ltd. beneficially owns 672,007 shares of Common Stock, representing 5.04% of the class as calculated on 13,336,392 shares outstanding provided by the issuer. The filing states the Reporting Person may acquire 377,350 Shares upon exercise of a pre-funded warrant within 60 days, subject to a 4.99% beneficial ownership blocker.
The Schedule 13G is signed by Lavi Krasney, Chief Executive Officer, and the reporting address and citizenship for Capitalink Ltd. are shown as Tel Aviv, Israel and Israel, respectively.
Viewbix Inc. director Yoresh Eliyahu acquired equity in the company through a share exchange with Quantum X Labs Ltd. On March 4, 2026, he received 179,159 shares of common stock and pre-funded warrants to purchase up to 88,675 additional common shares under a Securities Exchange Agreement.
The pre-funded warrants carry an exercise price of $0.0001 per share and will not expire until exercised in full. The filing also lists 2,518 common shares held indirectly through Yoresh Capital Ltd., which are reported for informational purposes with no new transaction in those securities.
Viewbix Inc. obtained written consent from holders of 51.93% of its common stock to approve three key actions without holding a shareholder meeting. Stockholders approved the issuance of up to 20,488,442 shares of common stock tied to a PIPE financing, warrants and the Quantum X Labs Ltd. acquisition, compared with 10,670,392 shares outstanding as of January 6, 2026. The PIPE is expected to raise about $1.4 million in gross proceeds, with additional proceeds possible from warrant exercises, and supports both funding and the Quantum transaction.
Holders also re-elected the existing board across all three director classes, keeping the staggered board structure in place. In addition, the board received discretionary authority to implement one or more reverse stock splits in a range from 1‑for‑2 up to 1‑for‑20 within two years, primarily to help maintain Nasdaq listing compliance and potentially broaden institutional interest. The reverse split would not change authorized shares, so it would increase the pool of unissued shares available for future use.
Viewbix Inc. entered into a securities exchange agreement to acquire at least 85% and up to 100% of Quantum X Labs Ltd. by issuing to Quantum shareholders up to 40.0% of Viewbix’s issued and outstanding capital stock as of December 15, 2025.
The consideration consists of up to 2,666,000 common shares, representing 19.99% of Viewbix’s capital, and pre-funded warrants to purchase up to 4,447,595 shares, with Quantum becoming a subsidiary at closing, which is expected within 90 days subject to due diligence, regulatory, stockholder and other customary approvals.
Quantum shareholders may also receive up to 12,702,847 additional earn-out shares or pre-funded warrants upon achieving milestones tied to five patent applications across at least three quantum sub-fields, a Portfolio Company transaction at a pre-money valuation of at least $20 million, and either a capital raise of at least $10 million or an M&A transaction for Quantum at a pre-money valuation of at least $250 million within up to a 48-month period, with all exchange shares and related warrant shares locked up for 12 months after closing.
Viewbix Inc. (VBIX) announced a new non-binding term sheet to acquire 100% of Quantum X Labs Ltd. The consideration would be equity-based: on a post-closing basis, Quantum’s sellers would receive Viewbix securities equal to 40.0% of the company’s issued and outstanding capital stock, delivered as (i) Common Stock equal to 19.99% (the “Exchange Shares”) and (ii) pre-funded warrants for the balance up to 40.0% (the “Exchange Pre-Funded Warrants”).
The term sheet also permits additional earn-out issuances upon milestones, capped so that Earn Out Securities do not represent more than 65.0% of the company’s issued and outstanding capital stock on a post-closing basis. Milestones include potential issuances of 6% (within 18 months of the Closing Date), an additional 8% (within 30 months), and an additional 11% (within 36 months), tied to prototype progress, collaboration agreements or patent filings, and beta validation.
Completion is subject to final due diligence, definitive agreements, regulatory approvals, stockholder approval under Nasdaq rules, and customary closing conditions.